Kazia Therapeutics reports early data from breast cancer trial patient
Go back to Kazia Therapeutics reports early data from breast cancer trial patient| (NASDAQ: KZIA) | Delayed: 13.79 +0.59 (4.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.20 | 52 Week High | $ | |||
| Open | $13.25 | 52 Week Low | $ | |||
| Day High | $13.98 | P/E | N/A | |||
| Day Low | $13.25 | EPS | $ | |||
| Volume | 92,936 | |||||
